EVAADE: A Study to Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Allografts

Sponsor
Centre Leon Berard (Other)
Overall Status
Withdrawn
CT.gov ID
NCT04331483
Collaborator
(none)
0
1
1
56.8
0

Study Details

Study Description

Brief Summary

To date, allogeneic haematopoietic stem cell transplantation (aHSCT) is the only curative treatment for many paediatric and young adult haematological pathologies (acute leukaemia, myelodysplastic syndromes, haemoglobinopathies, bone marrow aplasia, severe combined immunodeficiency). Despite the major therapeutic progress made over the last 50 years, particularly in terms of supportive care, post-transplant morbidity and mortality remains high. Infectious complications, whose incidence varies between 30 and 60%, are the first cause of mortality in the immediate post-transplant period.

In order to protect the patient from the occurrence of severe infectious episodes, aHSCTmust be performed in a highly protected environment (positive pressure chambers).

This has implications for the experience and impact of hospitalization on the patient and family. This is particularly true in paediatrics, whether in children, adolescents or young adults, where it is not only the patient's quality of life that is at stake, but also their emotional and psychomotor development. In these patients, prolonged hospitalization (at least 6 weeks) in a sterile room will be responsible for physical deconditioning accompanied by a decrease in muscle mass, itself concomitant with undernutrition, and an increase in sedentary lifestyle. This prolonged hospitalisation in a sterile room, associated with myeloablative treatments, is therefore the cause of social isolation of patients, but it is also often synonymous with physical inactivity leading to a rapid decrease in physical condition, quality of life and an increase in fatigue.

Today, the benefits of physical activity (PA) during and after cancer treatment have been widely demonstrated.

The objective is to evaluate the feasibility of an adapted physical activity program during the isolation phase for achieving aHSCT in children, adolescents and young adults. This is a prospective, interventional, monocentric cohort study conducted at the Institute of Paediatric Haematology and Oncology in Lyon. The intervention will take place during the isolation phase and consists of an adapted physical activity (APA) program defined at inclusion, integrating supervised sessions with an APA teacher, as well as autonomous sessions. The program is individualized according to age, aerobic capacity, and PA preferences. Sessions are also tailored to the biological, psychological, and social parameters of patients.

The total duration of the intervention is 3 months. To date, no PA studies have been performed in patients under 21 years of age requiring aGCSH during the sterile isolation phase. EVAADE will therefore be the first study in this population to offer an innovative procedure with a connected device.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
A Feasibility Study to Assess Connected Bikes as a Means of Adapted Physical Activity in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Allografts
Actual Study Start Date :
Dec 8, 2018
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Sep 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Physical activity intervention

The intervention consists of an adapted physical activity (APA) program defined at baseline, incorporating supervised sessions with an APA teacher, as well as autonomous sessions. The program is individualized according to age, aerobic capacity, and PA preferences. The total duration of the intervention is a maximum of 3 months (during the period of hospitalization in a sterile room).

Other: Physical activity program
Supervised sessions of at least 15 minutes 4 times a Week combined with unsupervised sessions. The supervised activities include moderate-intensity aerobic activities (exercise bike), muscle strengthening (dumbbells, elastic bands, medicine balls) and playful situations (ball games, cooperative games, body expression games). Each patient can also do unsupervised sessions, autonomously, on the bike thanks to a smartphone application developed by the Kiplin company, with challenges to be carried out by teams of 2 to 5 people (team including several patients, possibility to include relatives) over periods of 1 to 3 weeks per challenge.

Outcome Measures

Primary Outcome Measures

  1. Observance to the physical activity program [weekly from baseline to 3 months]

    achieved/non-achieved (achived meaning the patient attended at least one session of 15 minutes weekly during the whole program

Secondary Outcome Measures

  1. Impact of the physical activity program on weight [Baseline, 1 month and 3 months]

    weight in kgs

  2. Impact of the physical activity program on waist circumference [Baseline, 1 month and 3 months]

    assessed in cm

  3. Impact of the physical activity program on hip circumference [Baseline, 1 month and 3 months]

    assessed in cm

  4. Impact of the physical activity program on abdominal circumference [Baseline, 1 month and 3 months]

    assessed in cm

  5. Impact of the physical activity program on body mass index [Baseline, 1 month and 3 months]

    weight/(size)2

  6. Impact of the physical activity program on endurance capacity [Baseline, 1 month and 3 months]

    Harvard step test

  7. Impact of the physical activity program on muscle strength [Baseline, 1 month and 3 months]

    Dynamometer

  8. Impact of the physical activity program on fatigue [Baseline, 1 month and 3 months]

    Visual analogic scale from 0 to 10

  9. Self-efficacy feeling [3 months]

    HAPA questionnaire

  10. Motivation towards physical activity [Baseline, 1 month and 3 months]

    BREQ questionnaire

  11. Impact of the PA program on metabolic syndrome [Baseline and 3 months]

    Lipid check-up

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 21 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 8 years ≤ Age ≤ 21 years

  • Size more or equal to 110 cm.

  • Histologically or cytologically confirmed malignant or non-malignant haemopathy

  • Indication for hematopoietic stem cell allograft.

  • Hospitalization in a protected room at IHOP/DAJAC.

  • Certificate of no contraindication to the practice of an APA, issued by the oncologist or attending physician.

  • Having available in the sterile room a smartphone (iPhone 5S version for Apple/version 5 under Android at least) or a tablet (for the realization of the connected challenges) during the whole hospitalization period.

  • Written consent signed and dated by the patient or the parents of minor patients with the acceptance of the minor.

Exclusion Criteria:
  • Severe Heart Disease and Uncontrolled Cardiovascular Disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Institut d'Hématologie et d'Oncologie Pédiatrique Lyon France 69008

Sponsors and Collaborators

  • Centre Leon Berard

Investigators

  • Principal Investigator: Carine HALFON-DOMENECH, MD, Institut d'Hematologie et d'Oncologie Pédiatrique

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Leon Berard
ClinicalTrials.gov Identifier:
NCT04331483
Other Study ID Numbers:
  • EVAADE
  • ET 18-184
First Posted:
Apr 2, 2020
Last Update Posted:
Feb 28, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 28, 2022